Global Therapeutic Proteins and Oral Vaccines Supply, Demand and Key Producers, 2023-2029

Page: 124

Published Date: 23 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Therapeutic Proteins and Oral Vaccines market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Therapeutic proteins are engineered in the laboratory for pharmaceutical use. They include non-covalent binders, enzymes and albumin and therefore have a wide range of treatment applications. Oral vaccines are biologically prepared products, which provide active acquired immunity to diseases. There are currently oral vaccines targeting cholera, polio, rotavirus, smallpox and yellow fever, among others. Oral vaccines comprise an agent resembling the disease-causing microorganism, such as a live attenuated or killed viral particle or the micro-organisms toxins or surface proteins.

This report studies the global Therapeutic Proteins and Oral Vaccines demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Therapeutic Proteins and Oral Vaccines, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Therapeutic Proteins and Oral Vaccines that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Therapeutic Proteins and Oral Vaccines total market, 2018-2029, (USD Million)
Global Therapeutic Proteins and Oral Vaccines total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Therapeutic Proteins and Oral Vaccines total market, key domestic companies and share, (USD Million)
Global Therapeutic Proteins and Oral Vaccines revenue by player and market share 2018-2023, (USD Million)
Global Therapeutic Proteins and Oral Vaccines total market by Type, CAGR, 2018-2029, (USD Million)
Global Therapeutic Proteins and Oral Vaccines total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Therapeutic Proteins and Oral Vaccines market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Amgen, Biogen, Eli Lilly and Company, Roche, Johnson and Johnson, Merck, Novo Nordisk and Pfizer, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Therapeutic Proteins and Oral Vaccines market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Therapeutic Proteins and Oral Vaccines Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Therapeutic Proteins and Oral Vaccines Market, Segmentation by Type
    Therapeutic Proteins
    Oral Vaccines

Global Therapeutic Proteins and Oral Vaccines Market, Segmentation by Application
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies

Companies Profiled:
    Abbott
    Amgen
    Biogen
    Eli Lilly and Company
    Roche
    Johnson and Johnson
    Merck
    Novo Nordisk
    Pfizer
    Sanofi
    Serum Institute of India
    Emergent Biosolutions
    TransAlgae
    MigVax
    Lumen Bioscience

Key Questions Answered
1. How big is the global Therapeutic Proteins and Oral Vaccines market?
2. What is the demand of the global Therapeutic Proteins and Oral Vaccines market?
3. What is the year over year growth of the global Therapeutic Proteins and Oral Vaccines market?
4. What is the total value of the global Therapeutic Proteins and Oral Vaccines market?
5. Who are the major players in the global Therapeutic Proteins and Oral Vaccines market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Therapeutic Proteins and Oral Vaccines Introduction
    1.2 World Therapeutic Proteins and Oral Vaccines Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Therapeutic Proteins and Oral Vaccines Total Market by Region (by Headquarter Location)
        1.3.1 World Therapeutic Proteins and Oral Vaccines Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Therapeutic Proteins and Oral Vaccines Market Size (2018-2029)
        1.3.3 China Therapeutic Proteins and Oral Vaccines Market Size (2018-2029)
        1.3.4 Europe Therapeutic Proteins and Oral Vaccines Market Size (2018-2029)
        1.3.5 Japan Therapeutic Proteins and Oral Vaccines Market Size (2018-2029)
        1.3.6 South Korea Therapeutic Proteins and Oral Vaccines Market Size (2018-2029)
        1.3.7 ASEAN Therapeutic Proteins and Oral Vaccines Market Size (2018-2029)
        1.3.8 India Therapeutic Proteins and Oral Vaccines Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Therapeutic Proteins and Oral Vaccines Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Therapeutic Proteins and Oral Vaccines Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Therapeutic Proteins and Oral Vaccines Consumption Value (2018-2029)
    2.2 World Therapeutic Proteins and Oral Vaccines Consumption Value by Region
        2.2.1 World Therapeutic Proteins and Oral Vaccines Consumption Value by Region (2018-2023)
        2.2.2 World Therapeutic Proteins and Oral Vaccines Consumption Value Forecast by Region (2024-2029)
    2.3 United States Therapeutic Proteins and Oral Vaccines Consumption Value (2018-2029)
    2.4 China Therapeutic Proteins and Oral Vaccines Consumption Value (2018-2029)
    2.5 Europe Therapeutic Proteins and Oral Vaccines Consumption Value (2018-2029)
    2.6 Japan Therapeutic Proteins and Oral Vaccines Consumption Value (2018-2029)
    2.7 South Korea Therapeutic Proteins and Oral Vaccines Consumption Value (2018-2029)
    2.8 ASEAN Therapeutic Proteins and Oral Vaccines Consumption Value (2018-2029)
    2.9 India Therapeutic Proteins and Oral Vaccines Consumption Value (2018-2029)

3 World Therapeutic Proteins and Oral Vaccines Companies Competitive Analysis
    3.1 World Therapeutic Proteins and Oral Vaccines Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Therapeutic Proteins and Oral Vaccines Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Therapeutic Proteins and Oral Vaccines in 2022
        3.2.3 Global Concentration Ratios (CR8) for Therapeutic Proteins and Oral Vaccines in 2022
    3.3 Therapeutic Proteins and Oral Vaccines Company Evaluation Quadrant
    3.4 Therapeutic Proteins and Oral Vaccines Market: Overall Company Footprint Analysis
        3.4.1 Therapeutic Proteins and Oral Vaccines Market: Region Footprint
        3.4.2 Therapeutic Proteins and Oral Vaccines Market: Company Product Type Footprint
        3.4.3 Therapeutic Proteins and Oral Vaccines Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Therapeutic Proteins and Oral Vaccines Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Therapeutic Proteins and Oral Vaccines Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Therapeutic Proteins and Oral Vaccines Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Therapeutic Proteins and Oral Vaccines Consumption Value Comparison
        4.2.1 United States VS China: Therapeutic Proteins and Oral Vaccines Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Therapeutic Proteins and Oral Vaccines Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Therapeutic Proteins and Oral Vaccines Companies and Market Share, 2018-2023
        4.3.1 United States Based Therapeutic Proteins and Oral Vaccines Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Therapeutic Proteins and Oral Vaccines Revenue, (2018-2023)
    4.4 China Based Companies Therapeutic Proteins and Oral Vaccines Revenue and Market Share, 2018-2023
        4.4.1 China Based Therapeutic Proteins and Oral Vaccines Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Therapeutic Proteins and Oral Vaccines Revenue, (2018-2023)
    4.5 Rest of World Based Therapeutic Proteins and Oral Vaccines Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Therapeutic Proteins and Oral Vaccines Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Therapeutic Proteins and Oral Vaccines Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Therapeutic Proteins and Oral Vaccines Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Therapeutic Proteins
        5.2.2 Oral Vaccines
    5.3 Market Segment by Type
        5.3.1 World Therapeutic Proteins and Oral Vaccines Market Size by Type (2018-2023)
        5.3.2 World Therapeutic Proteins and Oral Vaccines Market Size by Type (2024-2029)
        5.3.3 World Therapeutic Proteins and Oral Vaccines Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Therapeutic Proteins and Oral Vaccines Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Hospital Pharmacies
        6.2.2 Retail Pharmacies
        6.2.3 Online Pharmacies
    6.3 Market Segment by Application
        6.3.1 World Therapeutic Proteins and Oral Vaccines Market Size by Application (2018-2023)
        6.3.2 World Therapeutic Proteins and Oral Vaccines Market Size by Application (2024-2029)
        6.3.3 World Therapeutic Proteins and Oral Vaccines Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Abbott
        7.1.1 Abbott Details
        7.1.2 Abbott Major Business
        7.1.3 Abbott Therapeutic Proteins and Oral Vaccines Product and Services
        7.1.4 Abbott Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Abbott Recent Developments/Updates
        7.1.6 Abbott Competitive Strengths & Weaknesses
    7.2 Amgen
        7.2.1 Amgen Details
        7.2.2 Amgen Major Business
        7.2.3 Amgen Therapeutic Proteins and Oral Vaccines Product and Services
        7.2.4 Amgen Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Amgen Recent Developments/Updates
        7.2.6 Amgen Competitive Strengths & Weaknesses
    7.3 Biogen
        7.3.1 Biogen Details
        7.3.2 Biogen Major Business
        7.3.3 Biogen Therapeutic Proteins and Oral Vaccines Product and Services
        7.3.4 Biogen Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Biogen Recent Developments/Updates
        7.3.6 Biogen Competitive Strengths & Weaknesses
    7.4 Eli Lilly and Company
        7.4.1 Eli Lilly and Company Details
        7.4.2 Eli Lilly and Company Major Business
        7.4.3 Eli Lilly and Company Therapeutic Proteins and Oral Vaccines Product and Services
        7.4.4 Eli Lilly and Company Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Eli Lilly and Company Recent Developments/Updates
        7.4.6 Eli Lilly and Company Competitive Strengths & Weaknesses
    7.5 Roche
        7.5.1 Roche Details
        7.5.2 Roche Major Business
        7.5.3 Roche Therapeutic Proteins and Oral Vaccines Product and Services
        7.5.4 Roche Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Roche Recent Developments/Updates
        7.5.6 Roche Competitive Strengths & Weaknesses
    7.6 Johnson and Johnson
        7.6.1 Johnson and Johnson Details
        7.6.2 Johnson and Johnson Major Business
        7.6.3 Johnson and Johnson Therapeutic Proteins and Oral Vaccines Product and Services
        7.6.4 Johnson and Johnson Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Johnson and Johnson Recent Developments/Updates
        7.6.6 Johnson and Johnson Competitive Strengths & Weaknesses
    7.7 Merck
        7.7.1 Merck Details
        7.7.2 Merck Major Business
        7.7.3 Merck Therapeutic Proteins and Oral Vaccines Product and Services
        7.7.4 Merck Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Merck Recent Developments/Updates
        7.7.6 Merck Competitive Strengths & Weaknesses
    7.8 Novo Nordisk
        7.8.1 Novo Nordisk Details
        7.8.2 Novo Nordisk Major Business
        7.8.3 Novo Nordisk Therapeutic Proteins and Oral Vaccines Product and Services
        7.8.4 Novo Nordisk Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Novo Nordisk Recent Developments/Updates
        7.8.6 Novo Nordisk Competitive Strengths & Weaknesses
    7.9 Pfizer
        7.9.1 Pfizer Details
        7.9.2 Pfizer Major Business
        7.9.3 Pfizer Therapeutic Proteins and Oral Vaccines Product and Services
        7.9.4 Pfizer Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Pfizer Recent Developments/Updates
        7.9.6 Pfizer Competitive Strengths & Weaknesses
    7.10 Sanofi
        7.10.1 Sanofi Details
        7.10.2 Sanofi Major Business
        7.10.3 Sanofi Therapeutic Proteins and Oral Vaccines Product and Services
        7.10.4 Sanofi Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Sanofi Recent Developments/Updates
        7.10.6 Sanofi Competitive Strengths & Weaknesses
    7.11 Serum Institute of India
        7.11.1 Serum Institute of India Details
        7.11.2 Serum Institute of India Major Business
        7.11.3 Serum Institute of India Therapeutic Proteins and Oral Vaccines Product and Services
        7.11.4 Serum Institute of India Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 Serum Institute of India Recent Developments/Updates
        7.11.6 Serum Institute of India Competitive Strengths & Weaknesses
    7.12 Emergent Biosolutions
        7.12.1 Emergent Biosolutions Details
        7.12.2 Emergent Biosolutions Major Business
        7.12.3 Emergent Biosolutions Therapeutic Proteins and Oral Vaccines Product and Services
        7.12.4 Emergent Biosolutions Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 Emergent Biosolutions Recent Developments/Updates
        7.12.6 Emergent Biosolutions Competitive Strengths & Weaknesses
    7.13 TransAlgae
        7.13.1 TransAlgae Details
        7.13.2 TransAlgae Major Business
        7.13.3 TransAlgae Therapeutic Proteins and Oral Vaccines Product and Services
        7.13.4 TransAlgae Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 TransAlgae Recent Developments/Updates
        7.13.6 TransAlgae Competitive Strengths & Weaknesses
    7.14 MigVax
        7.14.1 MigVax Details
        7.14.2 MigVax Major Business
        7.14.3 MigVax Therapeutic Proteins and Oral Vaccines Product and Services
        7.14.4 MigVax Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2018-2023)
        7.14.5 MigVax Recent Developments/Updates
        7.14.6 MigVax Competitive Strengths & Weaknesses
    7.15 Lumen Bioscience
        7.15.1 Lumen Bioscience Details
        7.15.2 Lumen Bioscience Major Business
        7.15.3 Lumen Bioscience Therapeutic Proteins and Oral Vaccines Product and Services
        7.15.4 Lumen Bioscience Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2018-2023)
        7.15.5 Lumen Bioscience Recent Developments/Updates
        7.15.6 Lumen Bioscience Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Therapeutic Proteins and Oral Vaccines Industry Chain
    8.2 Therapeutic Proteins and Oral Vaccines Upstream Analysis
    8.3 Therapeutic Proteins and Oral Vaccines Midstream Analysis
    8.4 Therapeutic Proteins and Oral Vaccines Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Therapeutic Proteins and Oral Vaccines Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Therapeutic Proteins and Oral Vaccines Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Therapeutic Proteins and Oral Vaccines Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Therapeutic Proteins and Oral Vaccines Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Therapeutic Proteins and Oral Vaccines Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Therapeutic Proteins and Oral Vaccines Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Therapeutic Proteins and Oral Vaccines Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Therapeutic Proteins and Oral Vaccines Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Therapeutic Proteins and Oral Vaccines Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Therapeutic Proteins and Oral Vaccines Players in 2022
    Table 12. World Therapeutic Proteins and Oral Vaccines Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Therapeutic Proteins and Oral Vaccines Company Evaluation Quadrant
    Table 14. Head Office of Key Therapeutic Proteins and Oral Vaccines Player
    Table 15. Therapeutic Proteins and Oral Vaccines Market: Company Product Type Footprint
    Table 16. Therapeutic Proteins and Oral Vaccines Market: Company Product Application Footprint
    Table 17. Therapeutic Proteins and Oral Vaccines Mergers & Acquisitions Activity
    Table 18. United States VS China Therapeutic Proteins and Oral Vaccines Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Therapeutic Proteins and Oral Vaccines Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Therapeutic Proteins and Oral Vaccines Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Therapeutic Proteins and Oral Vaccines Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Therapeutic Proteins and Oral Vaccines Revenue Market Share (2018-2023)
    Table 23. China Based Therapeutic Proteins and Oral Vaccines Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Therapeutic Proteins and Oral Vaccines Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Therapeutic Proteins and Oral Vaccines Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Therapeutic Proteins and Oral Vaccines Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Therapeutic Proteins and Oral Vaccines Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Therapeutic Proteins and Oral Vaccines Revenue Market Share (2018-2023)
    Table 29. World Therapeutic Proteins and Oral Vaccines Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Therapeutic Proteins and Oral Vaccines Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Therapeutic Proteins and Oral Vaccines Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Therapeutic Proteins and Oral Vaccines Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Therapeutic Proteins and Oral Vaccines Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Therapeutic Proteins and Oral Vaccines Market Size by Application (2024-2029) & (USD Million)
    Table 35. Abbott Basic Information, Area Served and Competitors
    Table 36. Abbott Major Business
    Table 37. Abbott Therapeutic Proteins and Oral Vaccines Product and Services
    Table 38. Abbott Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Abbott Recent Developments/Updates
    Table 40. Abbott Competitive Strengths & Weaknesses
    Table 41. Amgen Basic Information, Area Served and Competitors
    Table 42. Amgen Major Business
    Table 43. Amgen Therapeutic Proteins and Oral Vaccines Product and Services
    Table 44. Amgen Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Amgen Recent Developments/Updates
    Table 46. Amgen Competitive Strengths & Weaknesses
    Table 47. Biogen Basic Information, Area Served and Competitors
    Table 48. Biogen Major Business
    Table 49. Biogen Therapeutic Proteins and Oral Vaccines Product and Services
    Table 50. Biogen Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Biogen Recent Developments/Updates
    Table 52. Biogen Competitive Strengths & Weaknesses
    Table 53. Eli Lilly and Company Basic Information, Area Served and Competitors
    Table 54. Eli Lilly and Company Major Business
    Table 55. Eli Lilly and Company Therapeutic Proteins and Oral Vaccines Product and Services
    Table 56. Eli Lilly and Company Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Eli Lilly and Company Recent Developments/Updates
    Table 58. Eli Lilly and Company Competitive Strengths & Weaknesses
    Table 59. Roche Basic Information, Area Served and Competitors
    Table 60. Roche Major Business
    Table 61. Roche Therapeutic Proteins and Oral Vaccines Product and Services
    Table 62. Roche Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Roche Recent Developments/Updates
    Table 64. Roche Competitive Strengths & Weaknesses
    Table 65. Johnson and Johnson Basic Information, Area Served and Competitors
    Table 66. Johnson and Johnson Major Business
    Table 67. Johnson and Johnson Therapeutic Proteins and Oral Vaccines Product and Services
    Table 68. Johnson and Johnson Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Johnson and Johnson Recent Developments/Updates
    Table 70. Johnson and Johnson Competitive Strengths & Weaknesses
    Table 71. Merck Basic Information, Area Served and Competitors
    Table 72. Merck Major Business
    Table 73. Merck Therapeutic Proteins and Oral Vaccines Product and Services
    Table 74. Merck Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Merck Recent Developments/Updates
    Table 76. Merck Competitive Strengths & Weaknesses
    Table 77. Novo Nordisk Basic Information, Area Served and Competitors
    Table 78. Novo Nordisk Major Business
    Table 79. Novo Nordisk Therapeutic Proteins and Oral Vaccines Product and Services
    Table 80. Novo Nordisk Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Novo Nordisk Recent Developments/Updates
    Table 82. Novo Nordisk Competitive Strengths & Weaknesses
    Table 83. Pfizer Basic Information, Area Served and Competitors
    Table 84. Pfizer Major Business
    Table 85. Pfizer Therapeutic Proteins and Oral Vaccines Product and Services
    Table 86. Pfizer Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Pfizer Recent Developments/Updates
    Table 88. Pfizer Competitive Strengths & Weaknesses
    Table 89. Sanofi Basic Information, Area Served and Competitors
    Table 90. Sanofi Major Business
    Table 91. Sanofi Therapeutic Proteins and Oral Vaccines Product and Services
    Table 92. Sanofi Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. Sanofi Recent Developments/Updates
    Table 94. Sanofi Competitive Strengths & Weaknesses
    Table 95. Serum Institute of India Basic Information, Area Served and Competitors
    Table 96. Serum Institute of India Major Business
    Table 97. Serum Institute of India Therapeutic Proteins and Oral Vaccines Product and Services
    Table 98. Serum Institute of India Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. Serum Institute of India Recent Developments/Updates
    Table 100. Serum Institute of India Competitive Strengths & Weaknesses
    Table 101. Emergent Biosolutions Basic Information, Area Served and Competitors
    Table 102. Emergent Biosolutions Major Business
    Table 103. Emergent Biosolutions Therapeutic Proteins and Oral Vaccines Product and Services
    Table 104. Emergent Biosolutions Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. Emergent Biosolutions Recent Developments/Updates
    Table 106. Emergent Biosolutions Competitive Strengths & Weaknesses
    Table 107. TransAlgae Basic Information, Area Served and Competitors
    Table 108. TransAlgae Major Business
    Table 109. TransAlgae Therapeutic Proteins and Oral Vaccines Product and Services
    Table 110. TransAlgae Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 111. TransAlgae Recent Developments/Updates
    Table 112. TransAlgae Competitive Strengths & Weaknesses
    Table 113. MigVax Basic Information, Area Served and Competitors
    Table 114. MigVax Major Business
    Table 115. MigVax Therapeutic Proteins and Oral Vaccines Product and Services
    Table 116. MigVax Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 117. MigVax Recent Developments/Updates
    Table 118. Lumen Bioscience Basic Information, Area Served and Competitors
    Table 119. Lumen Bioscience Major Business
    Table 120. Lumen Bioscience Therapeutic Proteins and Oral Vaccines Product and Services
    Table 121. Lumen Bioscience Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 122. Global Key Players of Therapeutic Proteins and Oral Vaccines Upstream (Raw Materials)
    Table 123. Therapeutic Proteins and Oral Vaccines Typical Customers
List of Figure
    Figure 1. Therapeutic Proteins and Oral Vaccines Picture
    Figure 2. World Therapeutic Proteins and Oral Vaccines Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Therapeutic Proteins and Oral Vaccines Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Therapeutic Proteins and Oral Vaccines Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Therapeutic Proteins and Oral Vaccines Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Therapeutic Proteins and Oral Vaccines Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Therapeutic Proteins and Oral Vaccines Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Therapeutic Proteins and Oral Vaccines Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Therapeutic Proteins and Oral Vaccines Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Therapeutic Proteins and Oral Vaccines Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Therapeutic Proteins and Oral Vaccines Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Therapeutic Proteins and Oral Vaccines Revenue (2018-2029) & (USD Million)
    Figure 13. Therapeutic Proteins and Oral Vaccines Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Therapeutic Proteins and Oral Vaccines Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Therapeutic Proteins and Oral Vaccines Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Therapeutic Proteins and Oral Vaccines Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Therapeutic Proteins and Oral Vaccines Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Therapeutic Proteins and Oral Vaccines Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Therapeutic Proteins and Oral Vaccines Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Therapeutic Proteins and Oral Vaccines Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Therapeutic Proteins and Oral Vaccines Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Therapeutic Proteins and Oral Vaccines Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Therapeutic Proteins and Oral Vaccines by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Therapeutic Proteins and Oral Vaccines Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Therapeutic Proteins and Oral Vaccines Markets in 2022
    Figure 27. United States VS China: Therapeutic Proteins and Oral Vaccines Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Therapeutic Proteins and Oral Vaccines Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Therapeutic Proteins and Oral Vaccines Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Therapeutic Proteins and Oral Vaccines Market Size Market Share by Type in 2022
    Figure 31. Therapeutic Proteins
    Figure 32. Oral Vaccines
    Figure 33. World Therapeutic Proteins and Oral Vaccines Market Size Market Share by Type (2018-2029)
    Figure 34. World Therapeutic Proteins and Oral Vaccines Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 35. World Therapeutic Proteins and Oral Vaccines Market Size Market Share by Application in 2022
    Figure 36. Hospital Pharmacies
    Figure 37. Retail Pharmacies
    Figure 38. Online Pharmacies
    Figure 39. Therapeutic Proteins and Oral Vaccines Industrial Chain
    Figure 40. Methodology
    Figure 41. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Abbott
Amgen
Biogen
Eli Lilly and Company
Roche
Johnson and Johnson
Merck
Novo Nordisk
Pfizer
Sanofi
Serum Institute of India
Emergent Biosolutions
TransAlgae
MigVax
Lumen Bioscience

Related Reports

Global Therapeutic Proteins and Oral Vaccines Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Therapeutic Proteins and Oral Vaccines Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 10 Jan 2023

date Pharma & Healthcare

Therapeutic proteins are engineered in the laboratory for pharmaceutical use. They include non-covalent binders, enzymes and albumin and therefore have a wide range of treatment applications. Oral vaccines are biologically prepared products, which provide active acquired immunity to diseases. There are currently oral vaccines targeting cholera, polio, rotavirus, smallpox and yellow fever, among others. Oral vaccines comprise an agent resembling the disease-causing microorganism, such as a live attenuated or killed viral particle or the micro-organisms toxins or surface proteins.

Global Therapeutic Proteins and Oral Vaccines Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Therapeutic Proteins and Oral Vaccines Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 04 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Therapeutic Proteins and Oral Vaccines market size was valued at USD 438.3 million in 2023 and is forecast to a readjusted size of USD 643.8 million by 2030 with a CAGR of 5.6% during review period.

Global Therapeutic Proteins and Oral Vaccines Supply, Demand and Key Producers, 2024-2030

Global Therapeutic Proteins and Oral Vaccines Supply, Demand and Key Producers, 2024-2030

date 29 Feb 2024

date Pharma & Healthcare

The global Therapeutic Proteins and Oral Vaccines market size is expected to reach $ 643.8 million by 2030, rising at a market growth of 5.6% CAGR during the forecast period (2024-2030).

Product Tags

Therapeutic Proteins and Oral Vaccines

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>